Home > Compound List > Product Information
Saprisartan_Molecular_structure_CAS_146623-69-0)
Click picture or here to close

Saprisartan

Catalog No. DB01347 Name DrugBank
CAS Number 146623-69-0 Website http://www.ualberta.ca/
M. F. C25H22BrF3N4O4S Telephone (780) 492-3111
M. W. 611.4307896 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1176

SYNONYMS

IUPAC name
1-{[3-bromo-2-(2-trifluoromethanesulfonamidophenyl)-1-benzofuran-5-yl]methyl}-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide
IUPAC Traditional name
3-{[3-bromo-2-(2-trifluoromethanesulfonamidophenyl)-1-benzofuran-5-yl]methyl}-5-cyclopropyl-2-ethylimidazole-4-carboxamide

DATABASE IDS

PubChem SID 46508176
CAS Number 146623-69-0
PubChem CID 60921

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749)
Indication Saprisartan is used in the treatment of hypertension and heart failure.
Pharmacology By inhibiting the angiotensin II receptor, this drug leades to a decrease in sodium reabsorption and a decrease in vasoconstriction. This has the combined effect of decreasing blood pressure.
Affected Organisms
Humans and other mammals

REFERENCES